Study of Efficacy and Safety of AVTR101 in Sarcopenic Elderly
Clinical trial NCT06788236 · TERMINATED
Trial details
- NCT number
- NCT06788236
- Sponsor
- Aventi Biotechnology Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-23
- Primary completion
- 2024-06-14
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.